These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13272322)

  • 1. The modification of poliovirus antigens by heat and ultraviolet light.
    LE BOUVIER GL
    Lancet; 1955 Nov; 269(6898):1013-6. PubMed ID: 13272322
    [No Abstract]   [Full Text] [Related]  

  • 2. Variants of Poliovirus hominis. 4. Inactivation by heat, ultraviolet light and formaldehyde.
    DORMAN DC; LARKIN M; PONSFORD J; STANLEY NF
    Aust J Exp Biol Med Sci; 1956 Aug; 34(4):297-300. PubMed ID: 13363762
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on poliomyelitis virus. III. The use of ultra-violet light as an additional means of inactivation of formalinized vaccine.
    HAMPTON JW; POLSON A
    J Hyg (Lond); 1958 Jun; 56(2):266-70. PubMed ID: 13563868
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity of poliomyelitis vaccine prepared with ultraviolet irradiation and mild heat.
    SHAUGHNESSY HJ; WOLF AM; JANOTA M; NEAL J; OPPENHEIMER F; MILZER A; NAFTULIN H; MORRISSEY RA
    Proc Soc Exp Biol Med; 1957 Jun; 95(2):251-5. PubMed ID: 13441701
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of the homotypic specificity of poliomyelitis complement-fixing antigens by heat.
    SCHMIDT NJ; LENNETTE EH
    J Exp Med; 1956 Jul; 104(1):99-120. PubMed ID: 13332183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of poliomyelitis neutralizing antibody in disposable plastic panels.
    MELNICK JL; OPTON EM
    Bull World Health Organ; 1956; 14(1):129-46. PubMed ID: 13329842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological epidemiology of poliomyelitis; distribution of immunity to poliomyelitis virus.
    FALLON RJ
    Lancet; 1956 Jan; 270(6907):65-9. PubMed ID: 13287058
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of antibodies neutralizing poliomyelitis virus in blood of healthy children and adults].
    SAUTHOFF R
    Klin Wochenschr; 1956 May; 34(19-20):519-21. PubMed ID: 13333074
    [No Abstract]   [Full Text] [Related]  

  • 9. Poliovirus antibody in children in Northern Ireland.
    DANE DM; DICK GW; CONNOLLY JH; BRIGGS EM; MCLEOD WJ
    Lancet; 1956 Apr; 270(6921):481-3. PubMed ID: 13307971
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibodies against three types of poliomyelitis virus in infants and children of Palermo].
    ODDO FG; DE GRAZIA G
    Riv Ist Sieroter Ital; 1956; 31(1):39-45. PubMed ID: 13337024
    [No Abstract]   [Full Text] [Related]  

  • 11. Virus excretion and antibody response in clinical and subclinical cases of poliomyelitis.
    BROWN GC
    Ann N Y Acad Sci; 1955 Sep; 61(4):989-95; discussion, 995-7. PubMed ID: 13340607
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibodies against Col-SK virus in Mexican sera.
    JUNGEBLUT CW; BAUTISTA G
    Am J Trop Med Hyg; 1954 May; 3(3):466-74. PubMed ID: 13158767
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation of virus and the development of neutralizing and complement-fixing antibodies in poliomyelitic patients.
    MELNICK JL
    Ann N Y Acad Sci; 1955 Sep; 61(4):1005-10. PubMed ID: 13340609
    [No Abstract]   [Full Text] [Related]  

  • 14. [Incidence of neutralizing antibodies against three types of poliomyelitis virus in several population groups in northern Italy].
    GIOVANARDI A; MONACI V; BONETTI F
    Boll Ist Sieroter Milan; 1955; 34(11-12):742-8. PubMed ID: 13293260
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular immunity of monkeys versus antibody titers following oral inoculation with poliomyelitis virus.
    BACHTOLD JG; GEBHARDT LP; WILCOX WC; BUBEL HC
    J Immunol; 1955 Dec; 75(6):475-7. PubMed ID: 13271772
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody titer for seven different type 1 strains of poliomyelitis virus in children vaccinated with the Mahoney strain.
    YOUNGNER JS; SALK JE
    Am J Hyg; 1956 Mar; 63(2):198-203. PubMed ID: 13302208
    [No Abstract]   [Full Text] [Related]  

  • 17. [Isolation experiments and serological studies with poliomyelitis virus in tissue culture].
    PINTER M; ABRAHAM E; RAVNAY M
    Orv Hetil; 1956 Apr; 97(15):393-7. PubMed ID: 13335208
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the complement-fixing antibody titers of poliomyelitis and patients who are suspected of having poliomyelitis viruses infection-The movement of Y and H-antibody].
    KANEKO I
    Paediatr Jpn; 1962 Feb; 66():110-8. PubMed ID: 14453584
    [No Abstract]   [Full Text] [Related]  

  • 19. THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. I. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN KINETICS AND ANTIGEN DOSE REQUIREMENT FOR INDUCTION.
    SVEHAG SE; MANDEL B
    J Exp Med; 1964 Jan; 119(1):1-19. PubMed ID: 14113113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-fixing antigens of living and inactivated poliovirus. II. Complement-fixing activity of poliomyelitis vaccine and its relation to immunogenic potency.
    WARREN J; HARE JD; GOLDMAN C
    Am J Public Health Nations Health; 1959 Jan; 49(1):53-61. PubMed ID: 13617534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.